ArticlePloS one2022

Cost-effectiveness of the add-on exenatide to conventional treatment in patients with Parkinson's disease when considering the coexisting effects of diabetes mellitus.

Hsuan-Chih Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.